{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:21:53Z","timestamp":1776205313406,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Effective malaria vector control is being undermined by the rapid spread of insecticide resistance. VECTRON T500, a new indoor residual spraying (IRS) product containing the active ingredient broflanilide as a 50% wettable powder (WP), was previously shown to be efficacious in experimental hut trials. A two-arm non-inferiority cluster randomized controlled community trial was conducted in Muheza District, Tanga Region, Tanzania. VECTRON T500 was compared to the IRS product Fludora Fusion (clothianidin 50% + deltamethrin 6.25% WP-SB). Sixteen village clusters were pair-matched on baseline vector densities and allocated to reference and intervention arms. Monthly CDC light trapping sampled mosquitoes to estimate vector density, indoor biting, sporozoite and entomological inoculation rate (EIR). The non-inferiority margin of mosquito density was defined as a density ratio of 1.5. Susceptibility to IRS active ingredients was assessed in one of the local vectors, <jats:italic>Anopheles gambiae<\/jats:italic> sensu lato (s.l.), using WHO\/CDC bottle bioassays. The residual efficacy of both IRS products was monitored for 12 months using susceptible and pyrethroid resistant <jats:italic>An. gambiae<\/jats:italic> sensu stricto (s.s.) mosquitoes. This study is registered with ClinicalTrials.gov (NCT05150808). A total of 916 and 844 houses were sprayed with Fludora Fusion and VECTRON T500, respectively, with equitable spray coverage. <jats:italic>An. gambiae<\/jats:italic> s.l. was resistant to deltamethrin but susceptible to clothianidin and broflanilide. The density ratio adjusted for baseline Anopheline mosquito density was 0.77 (95% CI: 0.45\u20131.29). The baseline adjusted sporozoite rate and EIR differences between the two trial arms were 0.84% and 15.61%, respectively. The residual efficacy was &gt;\u200980% mortality for VECTRON T500 and Fludora Fusion, on both mud and concrete walls, 12 months post spraying. VECTRON T500 was non-inferior to Fludora Fusion in terms of its ability to reduce vector density, sporozoite rate and EIR, providing an additional vector control tool with a new mode of action for malaria prevention and insecticide resistance management.<\/jats:p>","DOI":"10.1038\/s41598-025-99809-9","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T07:59:22Z","timestamp":1745913562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A noninferiority cluster randomised evaluation of a broflanilide indoor residual spraying insecticide, VECTRON T500, for malaria vector control in Tanzania"],"prefix":"10.1038","volume":"15","author":[{"given":"Njelembo J.","family":"Mbewe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick K.","family":"Tungu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louisa A.","family":"Messenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter E.","family":"Mangesho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boniface","family":"Shirima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Moshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magreth F.","family":"Shayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Seif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie M.","family":"Portwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janneke","family":"Snetselaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salum","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Magogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Mabenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wema","family":"Sudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Mlay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franklin W.","family":"Mosha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Kisinza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnson","family":"Matowo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Small","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark W.","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"99809_CR1","unstructured":"World Health Organization. Global Plan for Insecticide Resistance Management in Malaria Vectors. (2012). https:\/\/apps.who.int\/iris\/handle\/10665\/44846"},{"key":"99809_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature15535","volume":"526","author":"S Bhatt","year":"2015","unstructured":"Bhatt, S. et al. The effect of malaria control on plasmodium falciparum in Africa between 2000 and 2015. Nature 526, 207\u2013211 (2015).","journal-title":"Nature"},{"key":"99809_CR3","unstructured":"WHO. World Malaria Report 2022 (WHO, 2022)."},{"key":"99809_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-016-1201-1","volume":"15","author":"RM Oxborough","year":"2016","unstructured":"Oxborough, R. M. Trends in US president\u2019s malaria Initiative-funded indoor residual spray coverage and insecticide choice in sub-Saharan Africa (2008\u20132015): urgent need for affordable, long-lasting insecticides. Malar. J. 15, 1\u20139 (2016).","journal-title":"Malar. J."},{"key":"99809_CR5","first-page":"17","volume-title":"Innovative Strategies for Vector Control- Ecology and Control of Vector-borne Diseases","author":"I Kleinschmidt","year":"2021","unstructured":"Kleinschmidt, I. & Rowland, M. Insecticides and malaria. In Innovative Strategies for Vector Control- Ecology and Control of Vector-borne Diseases Vol. 6 (eds Koenraadt, C. J. M. et al.) 17\u201332 (Wageningen Academic, 2021)."},{"key":"99809_CR6","doi-asserted-by":"publisher","first-page":"7976","DOI":"10.1038\/s41598-021-86935-3","volume":"11","author":"C Ngufor","year":"2021","unstructured":"Ngufor, C. et al. Efficacy of broflanilide (VECTRON T500), a new meta-diamide insecticide, for indoor residual spraying against pyrethroid-resistant malaria vectors. Sci. Rep. 11, 7976 (2021).","journal-title":"Sci. Rep."},{"key":"99809_CR7","doi-asserted-by":"publisher","first-page":"e0248026","DOI":"10.1371\/journal.pone.0248026","volume":"16","author":"J Snetselaar","year":"2021","unstructured":"Snetselaar, J. et al. Efficacy of indoor residual spraying with broflanilide (TENEBENAL), a novel meta- diamide insecticide, against pyrethroid- resistant anopheline vectors in Northern Tanzania : an experimental hut trial. PLoS One. 16, e0248026 (2021).","journal-title":"PLoS One"},{"key":"99809_CR8","doi-asserted-by":"crossref","unstructured":"Mbewe, N. J. et al. A non-inferiority and GLP-compliant study of broflanilide IRS (VECTRON\u2122 T500), a novel meta-diamide insecticide against Anopheles arabiensis. Front. Trop. Dis. 4 (2023).","DOI":"10.3389\/fitd.2023.1126869"},{"key":"99809_CR9","unstructured":"WHO. Prequalified Vector Control Products. Preprint at (2023). https:\/\/extranet.who.int\/pqweb\/vector-control-products\/prequalified-product-list?field_product_type_tid=83&field_pqt_vc_ref_number_value=&title=&field_applicant_tid=&field_active_ingredient_synergis_tid=&page=1"},{"key":"99809_CR10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.bmc.2015.08.008","volume":"24","author":"T Nakao","year":"2016","unstructured":"Nakao, T. & Banba, S. Broflanilide: A meta-diamide insecticide with a novel mode of action. Bioorg. Med. Chem. 24, 372\u2013377 (2016).","journal-title":"Bioorg. Med. Chem."},{"key":"99809_CR11","unstructured":"IRAC. IRAC Mode of Action Classification Scheme (IRAC, 2021)."},{"key":"99809_CR12","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12936-022-04336-x","volume":"21","author":"R Govoetchan","year":"2022","unstructured":"Govoetchan, R. et al. VECTRON\u2122 T500, a new broflanilide insecticide for indoor residual spraying, provides prolonged control of pyrethroid-resistant malaria vectors. Malar. J. 21, 324 (2022).","journal-title":"Malar. J."},{"key":"99809_CR13","doi-asserted-by":"publisher","first-page":"17852","DOI":"10.1038\/s41598-023-45047-w","volume":"13","author":"C Ngufor","year":"2023","unstructured":"Ngufor, C. et al. Community evaluation of VECTRON\u2122 T500, a broflanilide insecticide, for indoor residual spraying for malaria vector control in central Benin; a two arm non-inferiority cluster randomised trial. Sci. Rep. 13, 17852 (2023).","journal-title":"Sci. Rep."},{"key":"99809_CR14","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(18)30427-6","volume":"391","author":"N Protopopoff","year":"2018","unstructured":"Protopopoff, N. et al. Effectiveness of a long-lasting piperonyl butoxide-treated insecticidal net and indoor residual spray interventions, separately and together, against malaria transmitted by pyrethroid-resistant mosquitoes: a cluster, randomised controlled, two-by-two fact. Lancet 391, 1577\u20131588 (2018).","journal-title":"Lancet"},{"key":"99809_CR15","unstructured":"WHO. Determining Non-Inferiority of Insecticide-Treated Nets and Indoor Residual Spray Products within an Established Product Class (2018)."},{"key":"99809_CR16","doi-asserted-by":"publisher","first-page":"22359","DOI":"10.1038\/s41598-022-26990-6","volume":"12","author":"NM Portwood","year":"2022","unstructured":"Portwood, N. M. et al. Multi-centre discriminating concentration determination of broflanilide and potential for cross-resistance to other public health insecticides in Anopheles vector populations. Sci. Rep. 12, 22359 (2022).","journal-title":"Sci. Rep."},{"key":"99809_CR17","doi-asserted-by":"publisher","first-page":"e804","DOI":"10.1016\/S2542-5196(24)00172-4","volume":"8","author":"RM Oxborough","year":"2024","unstructured":"Oxborough, R. M., Chilito, K. C. F., Tokponnon, F. & Messenger, L. A. Malaria vector control in sub-Saharan Africa: complex trade-offs to combat the growing threat of insecticide resistance. Lancet Planet. Health. 8, e804\u2013e812 (2024).","journal-title":"Lancet Planet. Health"},{"key":"99809_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1475-2875-6-155","volume":"6","author":"C Bass","year":"2007","unstructured":"Bass, C., Williamson, M. S., Wilding, C. S., Donnelly, M. J. & Field, L. M. Identification of the main malaria vectors in the Anopheles gambiae species complex using a TaqMan real-time PCR assay. Malar. J. 6, 155 (2007).","journal-title":"Malar. J."},{"key":"99809_CR19","unstructured":"Wirtz, R., Avery, M., Benedict, M. & Sutcliffe, A. Plasmodium Sporozoite ELISA. in Field Techniques (ed. Dotson, E. M.) (2015)."},{"key":"99809_CR20","doi-asserted-by":"publisher","first-page":"13457","DOI":"10.1038\/s41598-021-92741-8","volume":"11","author":"NS Matowo","year":"2021","unstructured":"Matowo, N. S. et al. An increasing role of pyrethroid-resistant Anopheles funestus in malaria transmission in the lake zone, Tanzania. Sci. Rep. 11, 13457 (2021).","journal-title":"Sci. Rep."},{"key":"99809_CR21","doi-asserted-by":"publisher","first-page":"e370","DOI":"10.1016\/S2542-5196(23)00048-7","volume":"7","author":"NS Matowo","year":"2023","unstructured":"Matowo, N. S. et al. Differential impact of dual-active ingredient long-lasting insecticidal Nets on primary malaria vectors: a secondary analysis of a 3-year, single-blind, cluster-randomised controlled trial in rural Tanzania. Lancet Planet. Health. 7, e370\u2013e380 (2023).","journal-title":"Lancet Planet. Health"},{"key":"99809_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12879-022-07138-3","volume":"22","author":"PK Tungu","year":"2022","unstructured":"Tungu, P. K. et al. Large-scale (Phase III) evaluation of broflanilide 50WP (VECTRON\u2122 T500) for indoor residual spraying for malaria vector control in Northeast Tanzania: study protocol for a two-arm, non-inferiority, cluster-randomised community trial. BMC Infect. Dis. 22, 171 (2022).","journal-title":"BMC Infect. Dis."},{"key":"99809_CR23","unstructured":"Statistics, N. B. O. 2012 Population and Housing Census. (2012)."},{"key":"99809_CR24","first-page":"1","volume":"16","author":"G Mtove","year":"2016","unstructured":"Mtove, G. et al. The effectiveness of non-pyrethroid insecticide-treated durable wall lining to control malaria in rural Tanzania: study protocol for a two-armed cluster randomized trial. BMC Public. Health. 16, 1\u201315 (2016).","journal-title":"BMC Public. Health"},{"key":"99809_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/mve.12036","volume":"28","author":"B Kabula","year":"2014","unstructured":"Kabula, B. et al. Distribution and spread of pyrethroid and DDT resistance among the Anopheles gambiae complex in Tanzania. Med. Vet. Entomol. 28, 244\u2013252 (2014).","journal-title":"Med. Vet. Entomol."},{"key":"99809_CR26","doi-asserted-by":"publisher","unstructured":"Hayes, R. J. & Moulton, L. H. Cluster Randomised Trials. Cluster Randomised Trials, Second Edition (Chapman and Hall\/CRC, 2017). https:\/\/doi.org\/10.4324\/9781315370286","DOI":"10.4324\/9781315370286"},{"key":"99809_CR27","unstructured":"WHO. Indoor Residual Spraying, an Operational Manual for Indoor Residual Spraying (IRS) for Malaria Transmission Control and Elimination (WHO, 2015)."},{"key":"99809_CR28","unstructured":"WHO. Guidelines for Testing Mosquito Adulticides for Indoor Residual Spraying and Treatment of Mosquito Nets (WHO, 2006)."},{"key":"99809_CR29","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3390\/insects12080710","volume":"12","author":"S Azizi","year":"2021","unstructured":"Azizi, S. et al. Colonization and authentication of the Pyrethroid-Resistant Anopheles gambiae S.s. Muleba-Kis strain; an important test system for laboratory screening of new insecticides. Insects 12, 710 (2021).","journal-title":"Insects"},{"key":"99809_CR30","doi-asserted-by":"crossref","unstructured":"Govoetchan, R. et al. Investigating discriminating concentrations for monitoring susceptibility to broflanilide and cross resistance to other insecticide classes in Anopheles gambiae sensu Lato, using the new WHO bottle bioassay method. PLoS One 18, (2023).","DOI":"10.1371\/journal.pone.0276246"},{"key":"99809_CR31","unstructured":"CDC. Guideline for Evaluating Insecticide Resistance in Vectors Using the CDC Bottle Bioassay (CDC, 2010)."},{"key":"99809_CR32","unstructured":"WHO. Determining Discriminating Concentrations of Insecticides for Monitoring Resistance in Mosquitoes: Report of a Multi-Centre Laboratory Study and WHO Expert Consultation. (2022)."},{"key":"99809_CR33","unstructured":"WHO. Test Procedures for Insecticide Resistance Monitoring in Malaria Vector Mosquitoes (WHO, 2016)."},{"key":"99809_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/1475-2875-10-195","volume":"10","author":"L Durnez","year":"2011","unstructured":"Durnez, L. et al. False positive circumsporozoite protein ELISA: a challenge for the Estimation of the entomological inoculation rate of malaria and for vector incrimination. Malar. J. 10, 195 (2011).","journal-title":"Malar. J."},{"key":"99809_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1475-2875-6-111","volume":"6","author":"C Bass","year":"2007","unstructured":"Bass, C. et al. Detection of knockdown resistance (kdr) mutations in Anopheles Gambiae: a comparison of two new high-throughput assays with existing methods. Malar. J. 6, 111 (2007).","journal-title":"Malar. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99809-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99809-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99809-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T07:59:30Z","timestamp":1745913570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99809-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99809"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99809-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"7 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the ethical review committee of the Ministry of Health in Tanzania (NIMR\/HQ\/R.8a\/VOL.IX\/3520), and the institutional review board of LSHTM (N\u00b0 22,459). The study was registered on clinicaltrials.gov (NCT05150808, registered on 26 November 2021). The study was conducted according to the Declaration of Helsinki and the International Guidelines for Ethical Review of Epidemiological Studies. The protocol of the study was reviewed by the independent Expert Scientific Advisory Committee of the IVCC and by the WHO Pre-qualification Vector Control Team (WHO PQT\/VCT). Community consent was obtained from village leaders. Individual verbal and written informed consent were obtained from family heads, household members and qualitative study participants. All households within each community were offered IRS.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"15013"}}